The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Unfortunately, as By Health are the first company (to eat crabs) to submit to SAMR for a new permitted health function claim we have nothing to compare against with regards to timescales.
Hopefully it will take no longer than the times stated earlier for Blue Cap submissions but there has been no indication in the press regarding timescales. Probably because no one knows.
Anytime now or up to 7/10 months
So it. Looks like the majority (80) were submitted in 2021 and got bluehat in the first few months of 2022, so about 10 months - 1 year ,but 54 applied in April 2022 and were granted bluehat before June 2022 so 3 months ,
Fingers crossed
A total of 134 products were successfully registered in the first 6 months of 2022. Of which, 80 products had filed for registration last year, whilst the remaining 54 had filed for registration this year (2022).
https://www.foodnavigator-asia.com/Article/2022/07/20/most-blue-hat-health-foods-approved-this-year-made-immune-antioxidant-claims
It’s a bit vague, but gives a bit of an idea on the timeframe for product blue hat registration.
Pumpky, are you still nursing your backside when talking nonsense 🤡
Can see that the application for approval is for qingluo(Fruitflow) neoluoxin and Light luoxin, so maybe 3 submissions
But DSM are still taking a large chunk of change. Step down 2 starts Jan 01st, which should improve our situation.
DSM gave us £170k this year so you can only think that their share of the AA was at least 2 or 3 times what we received ,so £340 or £510 k plus the £390k of our revenue , starts to sound a bit tasty if you add those up .imo
Would be good to know how many products are with SAMR for approval. We know BH have a couple ready to launch and we know that FF+O3 agreement was complimentary to the BH agreement. I can only imagine that FF+O3 is part of the approvals too. So at least 3 products will be launch ready when approved. I'm sure that more than 3 will be with SAMR for approval. The BH strategy is to create a number of product formulas, keeping the best formulas for themselves and offering others to customers.
Notice it states “orders” not order, so maybe that x number of products launched. Imo
Pumpky. The Bod have told us many many times , .......The Company has previously stated that if BYHEALTH is successful in obtaining a new permitted health function claim in China for functional health foods, such as Fruitflow, that can demonstrate an anti-platelet effect, it is expected that this would result in some significant orders for Fruitflow, potentially at a multiple of current total sales values.... so 5x 10 x or even 20x . £390k also x ‘s what DSM revenue is
I would assume the evaluation methods have been reviewed and approved by SAMR before the work commenced, or perhaps alongside the study work. It was likely this that results in the test scope changing, which resulted in a changing number of studies. Then SAMR reps are involved in the testing and submission. So I think approval is pretty much a box ticking exercise.
We are coming up to 3 months since submission. It is a dual track submission, FF + Products. We know that Product approval use to take years, but these days it has been reduced to 6 months from submission. So if FF can be done within that timescale, then the product approvals will be the critical path and land us in 2024 Q1. It's all guesswork.
Obviously they are confident:question should be "How much will Pxs make out of it?
"spend years and millions on trying"
I doubt By-Health would have done the above if the weren't confident.
I have no doubts.
Makes you wonder if this is not approved who else would spend years and millions on trying ! IMO we must get approval .
"......In the context of my country's aging population, the overall risk of cardiovascular disease is increasing year by year. Platelet aggregation, as an important factor in maintaining cardiovascular health, has attracted increasing attention from the scientific community. Liang Shuisheng pointed out that based on By-Health’s insight into the development of cardiovascular health issues, in 2015 it aimed at the new function of “maintaining normal platelet aggregation function” and used this as a breakthrough point to use water-soluble tomato concentrate (Qingluo element), carried out research and development work for 8 years to maintain new functions of normal platelet aggregation, and cooperated with many authoritative institutions such as the Institute of Traditional Chinese Medicine of the Chinese Academy of Chinese Medical Sciences, the Institute of Gerontology of the Chinese Academy of Medical Sciences, and Sun Yat-sen University to systematically establish for the first time "help "Maintain normal platelet aggregation function" health food evaluation method, completed clinical verification and related mechanism research on the impact of blood flow health on the Chinese population, and submitted a new function application after the implementation of the "Implementation Rules" in order to meet the growing number of consumers meet the needs for health and provide consumers with more scientifically segmented functional products....."
https://baijiahao-baidu-com.translate.goog/s?id=1783226352026969518&wfr=spider&for=pc&_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
https://baijiahao-baidu-com.translate.goog/s?id=1783234983060378308&wfr=spider&for=pc&_x_tr_sl=auto&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp
Could be buys ! Looks more like some sort of transfer .
2 x 17 million trades delayed from Friday showing today.
Think the Bod claimed that award years ago.
Talking of profit, this bloke bought all of his shares at the high point, where speculation exceeded facts by a huge marging, then he sold almost all of his shares at the low, when, again, the speculation exceeded the known facts in the negative.
There must be a "worst Ever" award in there somewhere surely.
14 long years and yet to turn a profit. What an absolute dog of a company poorly led IMO. Excellent product though!
Whereas you believe that execs should work for free.
I don't think anyone could explain the logic of that point of view. You can come and go as you please, they have to invest their time to maintain continuity, without which there would be no company.
G figure
The good news Naz is the Bod are still getting their full remuneration .
I’d forget about them and check them again in 2 years.
I'd go for option C Nazir:
Buy more, worry less...